What is the Fiscal Year for Endo Pharmaceuticals?
Date: November 13, 2026
Endo Pharmaceuticals's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q3, which ends on October 1, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q3
Current Quarter End
October 1, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Pennsylvania, United States
Industry
Pharmaceutical Manufacturing
Stock Symbol
ENDP
Website
https://endo.comDescription
Endo combined with Mallinckrodt Pharmaceuticals in 2025 to better serve customers and improve outcomes for the patients we support. From this union, we established two focused, standalone companies: – Keenova Therapeutics, a branded therapeutics business – Par Health, a generics and sterile injectables business To learn more, follow Keenova and Par Health on LinkedIn and visit keenova.com and parhealth.com.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Endo Pharmaceuticals and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.